[Imipenem/cilastatin/relebactam (bacterial infections) - Assessment according to §35a (para. 1c) Social Code Book V]

Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018004140
German
Original Title: Imipenem/Cilastatin/Relebactam (bakterielle Infektionen, mehrere Anwendungsgebiete)
Details
Project Status: Completed
URL for project: https://www.iqwig.de/projekte/g22-17.html
Year Published: 2022
URL for published report: https://www.iqwig.de/download/g22-17_imipenem-cilastatin-relebactam_bewertung-35a-absatz-1c-sgb-v_v1-0.pdf
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Gram-Negative Bacterial Infections
  • Anti-Bacterial Agents
  • Cilastatin
  • Cilastatin, Imipenem Drug Combination
  • Bacteremia
Keywords
  • Imipenem
  • Cilastatin
  • Relebactam
  • Healthcare-Associated Pneumonia
  • Bacteremia
  • GramNegative Bacterial Infections
  • Health Care Costs
  • Epidemiology
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.